Citation

Pitchot W, Reggers J, Pinto E, Hansenne M, Ansseau M. Neuropsychobiology 2003; 47(3): 152-157.

Copyright

(Copyright © 2003, Karger Publishers)

DOI

10.1159/000070585

PMID

12759559

Abstract

A large body of evidence suggests a potential role for catecholaminergic function as a possible biological factor in the control of suicidal behavior. Recently, we have used a neuroendocrine strategy to study dopaminergic and noradrenergic activities in depressed suicide attempters. However, some problems are associated with the use of growth hormone (GH) response to catecholaminergic challenge, because GH release could be decreased by a direct effect of corticosteroids at the pituitary level. Therefore, the purpose of the present study was to assess GH response to both apomorphine, a dopaminergic agonist, and clonidine, an alpha2-adrenergic agonist, according to the dexamethasone suppression test (DST) status in a sample of 20 major depressed inpatients with a history of suicide attempt compared with nonattempters. Our results tended to show that hypercortisolemia as assessed by post-DST cortisol values did not inhibit GH response to apomorphine or clonidine, suggesting that hypothalamo-pituitary-adrenal axis overactivity does not explain the impaired GH response to apomorphine in major depressed patients with a history of suicide attempt.

Language: en

Keywords

Adrenergic alpha-Agonists; Adult; Apomorphine; Catecholamines; Clonidine; Depressive Disorder, Major; Dexamethasone; Dopamine Agonists; Glucocorticoids; Growth Hormone; Humans; Hypothalamo-Hypophyseal System; Male; Pituitary-Adrenal System; Suicide, Attempted